Crescentic Glomerulonephritis: An Update on Pauci-immune and Anti-GBM DiseasesKambham, Neeraja MDAdvances in Anatomic Pathology: March 2012 - Volume 19 - Issue 2 - p 111–124 doi: 10.1097/PAP.0b013e318248b7a1 Review Articles Abstract Author Information Crescentic glomerulonephritis (GN) in a renal biopsy is a widely accepted “critical diagnosis” in Anatomic Pathology practice. Prompt biopsy evaluation and notification of the referring physician is essential to facilitate rapid therapeutic intervention. The differential diagnostic categories of crescentic GN include pauci-immune GN, anti-glomerular basement membrane (GBM) nephritis and immune complex-mediated GN, distinguished from one another by immunofluorescence and electron microscopic study of the renal biopsy. Immune complex-mediated GN is characterized by abundant glomerular deposits and encompasses several diseases including but not limited to lupus nephritis, cryoglobulinemic GN and immunoglobulin A nephropathy. Pauci-immune GN, with paucity of deposits, correlates closely with antineutrophil cytoplasmic antibody disease due to the identifiable circulating pathogenic antineutrophil cytoplasmic antibody in most patients. Recent studies have identified other antibodies in pauci-immune GN and implicated infectious organisms in triggering autoimmunity in a susceptible host by molecular mimicry of host antigens. Anti-GBM nephritis is a rare but potentially life-threatening autoimmune disease with circulating antibodies against GBM epitopes in α3 chain of type IV collagen. It is characterized by a linear immunoglobulin G deposition along GBM on immunofluorescence microscopy. Environmental triggers including infections and solvent exposure seem to change the tertiary structure of the type IV collagen α345 hexamer in GBM, expose neoepitopes, and initiate autoimmunity. Even in light of advances in understanding of pathophysiology and serologic testing, renal biopsy remains the mainstay of diagnosis of crescentic GN. Department of Pathology, Stanford University Medical Center, Stanford, CA The author has no funding or conflicts of interest to disclose. Reprints: Neeraja Kambham, MD, Department of Pathology, Stanford University Medical Center, Rm H2110, 300 Pasteur Drive, Stanford, CA (e-mail: email@example.com). © 2012 Lippincott Williams & Wilkins, Inc.